-
1
-
-
0037129380
-
Nonalcoholic fatty liver disease
-
Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-31.
-
(2002)
N Engl J Med
, vol.346
, pp. 1221-1231
-
-
Angulo, P.1
-
2
-
-
39149104311
-
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
-
Marra F, Gastaldelli A, Svegliati Baroni G, Tell G, Tiribelli C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med 2008; 14: 72-81.
-
(2008)
Trends Mol Med
, vol.14
, pp. 72-81
-
-
Marra, F.1
Gastaldelli, A.2
Svegliati Baroni, G.3
Tell, G.4
Tiribelli, C.5
-
3
-
-
33747517955
-
The epidemiology of nonalcoholic fatty liver disease in adults
-
Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006; 40 (Suppl 1): S5-10.
-
(2006)
J Clin Gastroenterol
, vol.40
, Issue.1 SUPPL.
-
-
Clark, J.M.1
-
4
-
-
32844458032
-
Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it
-
Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006; 6: 1-28.
-
(2006)
Mitochondrion
, vol.6
, pp. 1-28
-
-
Begriche, K.1
Igoudjil, A.2
Pessayre, D.3
Fromenty, B.4
-
5
-
-
4043077961
-
Molecular mediators of hepatic steatosis and liver injury
-
Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004; 114: 147-52.
-
(2004)
J Clin Invest
, vol.114
, pp. 147-152
-
-
Browning, J.D.1
Horton, J.D.2
-
6
-
-
22344452893
-
The natural history of nonalcoholic fatty liver disease: a population-based cohort study
-
Adams LA, Lymp JF, St Sauver J etal. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129: 113-21.
-
(2005)
Gastroenterology
, vol.129
, pp. 113-121
-
-
Adams, L.A.1
Lymp, J.F.2
St Sauver, J.3
-
7
-
-
34249699540
-
Non-alcoholic steatohepatitis and cancer
-
x-xi
-
Bugianesi E. Non-alcoholic steatohepatitis and cancer. Clin Liver Dis 2007; 11: 191-207. x-xi.
-
(2007)
Clin Liver Dis
, vol.11
, pp. 191-207
-
-
Bugianesi, E.1
-
8
-
-
56649083495
-
Mechanisms of disease progression in nonalcoholic fatty liver disease
-
Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis 2008; 28: 370-9.
-
(2008)
Semin Liver Dis
, vol.28
, pp. 370-379
-
-
Jou, J.1
Choi, S.S.2
Diehl, A.M.3
-
9
-
-
54549119175
-
The global impact of hepatic fibrosis and end-stage liver disease
-
vii
-
Lim YS, Kim WR. The global impact of hepatic fibrosis and end-stage liver disease. Clin Liver Dis 2008; 12: 733-46. vii.
-
(2008)
Clin Liver Dis
, vol.12
, pp. 733-746
-
-
Lim, Y.S.1
Kim, W.R.2
-
10
-
-
33748301260
-
Global challenges in liver disease
-
Williams R. Global challenges in liver disease. Hepatology 2006; 44: 521-6.
-
(2006)
Hepatology
, vol.44
, pp. 521-526
-
-
Williams, R.1
-
11
-
-
41849123475
-
Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment
-
Carter-Kent C, Zein NN, Feldstein AE. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment. Am J Gastroenterol 2008; 103: 1036-42.
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 1036-1042
-
-
Carter-Kent, C.1
Zein, N.N.2
Feldstein, A.E.3
-
12
-
-
33644547706
-
Nonalcoholic fatty liver disease: from steatosis to cirrhosis
-
Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43: S99-S112.
-
(2006)
Hepatology
, vol.43
-
-
Farrell, G.C.1
Larter, C.Z.2
-
13
-
-
54049150442
-
Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis
-
Anderson N, Borlak J. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. Pharmacol Rev 2008; 60: 311-57.
-
(2008)
Pharmacol Rev
, vol.60
, pp. 311-357
-
-
Anderson, N.1
Borlak, J.2
-
14
-
-
56649094325
-
Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease
-
Malhi H, Gores GJ. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis 2008; 28: 360-9.
-
(2008)
Semin Liver Dis
, vol.28
, pp. 360-369
-
-
Malhi, H.1
Gores, G.J.2
-
15
-
-
0038532298
-
A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids
-
Chavez JA, Knotts TA, Wang LP etal. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 2003; 278: 10297-303.
-
(2003)
J Biol Chem
, vol.278
, pp. 10297-10303
-
-
Chavez, J.A.1
Knotts, T.A.2
Wang, L.P.3
-
16
-
-
33847332202
-
Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance
-
Holland WL, Brozinick JT, Wang LP etal. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 2007; 5: 167-79.
-
(2007)
Cell Metab
, vol.5
, pp. 167-179
-
-
Holland, W.L.1
Brozinick, J.T.2
Wang, L.P.3
-
17
-
-
84860493578
-
Lipid mediators of insulin resistance
-
Holland WL, Knotts TA, Chavez JA, Wang LP, Hoehn KL, Summers SA. Lipid mediators of insulin resistance. Nutr Rev 2007; 65: S39-46.
-
(2007)
Nutr Rev
, vol.65
-
-
Holland, W.L.1
Knotts, T.A.2
Chavez, J.A.3
Wang, L.P.4
Hoehn, K.L.5
Summers, S.A.6
-
18
-
-
34250303939
-
Key role for ceramides in mediating insulin resistance in human muscle cells
-
Pickersgill L, Litherland GJ, Greenberg AS, Walker M, Yeaman SJ. Key role for ceramides in mediating insulin resistance in human muscle cells. J Biol Chem 2007; 282: 12583-9.
-
(2007)
J Biol Chem
, vol.282
, pp. 12583-12589
-
-
Pickersgill, L.1
Litherland, G.J.2
Greenberg, A.S.3
Walker, M.4
Yeaman, S.J.5
-
19
-
-
67649231047
-
The role of skeletal muscle sphingolipids in the development of insulin resistance
-
Straczkowski M, Kowalska I. The role of skeletal muscle sphingolipids in the development of insulin resistance. Rev Diabet Stud 2008; 5: 13-24.
-
(2008)
Rev Diabet Stud
, vol.5
, pp. 13-24
-
-
Straczkowski, M.1
Kowalska, I.2
-
20
-
-
4344614649
-
Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B
-
Stratford S, Hoehn KL, Liu F, Summers SA. Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B. J Biol Chem 2004; 279: 36608-15.
-
(2004)
J Biol Chem
, vol.279
, pp. 36608-36615
-
-
Stratford, S.1
Hoehn, K.L.2
Liu, F.3
Summers, S.A.4
-
21
-
-
31644443192
-
Ceramides in insulin resistance and lipotoxicity
-
Summers SA. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 2006; 45: 42-72.
-
(2006)
Prog Lipid Res
, vol.45
, pp. 42-72
-
-
Summers, S.A.1
-
22
-
-
58149144739
-
Sphingolipids: players in the pathology of metabolic disease
-
Cowart LA. Sphingolipids: players in the pathology of metabolic disease. Trends Endocrinol Metab 2009; 20: 34-42.
-
(2009)
Trends Endocrinol Metab
, vol.20
, pp. 34-42
-
-
Cowart, L.A.1
-
23
-
-
38549152194
-
Principles of bioactive lipid signalling: lessons from sphingolipids
-
Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 2008; 9: 139-50.
-
(2008)
Nat Rev Mol Cell Biol
, vol.9
, pp. 139-150
-
-
Hannun, Y.A.1
Obeid, L.M.2
-
24
-
-
45149106053
-
Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism
-
Holland WL, Summers SA. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev 2008; 29: 381-402.
-
(2008)
Endocr Rev
, vol.29
, pp. 381-402
-
-
Holland, W.L.1
Summers, S.A.2
-
25
-
-
0037401894
-
Intracellular signal transduction pathways activated by ceramide and its metabolites
-
Ruvolo PP. Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol Res 2003; 47: 383-92.
-
(2003)
Pharmacol Res
, vol.47
, pp. 383-392
-
-
Ruvolo, P.P.1
-
26
-
-
1542358155
-
Ceramide synthesis and metabolism as a target for cancer therapy
-
Reynolds CP, Maurer BJ, Kolesnick RN. Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett 2004; 206: 169-80.
-
(2004)
Cancer Lett
, vol.206
, pp. 169-180
-
-
Reynolds, C.P.1
Maurer, B.J.2
Kolesnick, R.N.3
-
28
-
-
21244442275
-
Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling
-
Chavez JA, Holland WL, Bar J, Sandhoff K, Summers SA. Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling. J Biol Chem 2005; 280: 20148-53.
-
(2005)
J Biol Chem
, vol.280
, pp. 20148-20153
-
-
Chavez, J.A.1
Holland, W.L.2
Bar, J.3
Sandhoff, K.4
Summers, S.A.5
-
29
-
-
0033575310
-
Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid
-
Chalfant CE, Kishikawa K, Mumby MC, Kamibayashi C, Bielawska A, Hannun YA. Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid. J Biol Chem 1999; 274: 20313-17.
-
(1999)
J Biol Chem
, vol.274
, pp. 20313-20317
-
-
Chalfant, C.E.1
Kishikawa, K.2
Mumby, M.C.3
Kamibayashi, C.4
Bielawska, A.5
Hannun, Y.A.6
-
31
-
-
46649108016
-
Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1
-
Shah C, Yang G, Lee I, Bielawski J, Hannun YA, Samad F. Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1. J Biol Chem 2008; 283: 13538-48.
-
(2008)
J Biol Chem
, vol.283
, pp. 13538-13548
-
-
Shah, C.1
Yang, G.2
Lee, I.3
Bielawski, J.4
Hannun, Y.A.5
Samad, F.6
-
32
-
-
34547558619
-
Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity
-
Kolak M, Westerbacka J, Velagapudi VR etal. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 2007; 56: 1960-8.
-
(2007)
Diabetes
, vol.56
, pp. 1960-1968
-
-
Kolak, M.1
Westerbacka, J.2
Velagapudi, V.R.3
-
33
-
-
67649687040
-
Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis
-
Lyn-Cook LE, Jr, Lawton M, Tong M etal. Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis. J Alzheimers Dis 2009; 16: 715-29.
-
(2009)
J Alzheimers Dis
, vol.16
, pp. 715-729
-
-
Lyn-Cook Jr., L.E.1
Lawton, M.2
Tong, M.3
-
34
-
-
0035735293
-
Nile Red binding to HepG2 cells: an improved assay for in vitro studies of hepatosteatosis
-
McMillian MK, Grant ER, Zhong Z etal. Nile Red binding to HepG2 cells: an improved assay for in vitro studies of hepatosteatosis. In Vitr Mol Toxicol 2001; 14: 177-90.
-
(2001)
In Vitr Mol Toxicol
, vol.14
, pp. 177-190
-
-
McMillian, M.K.1
Grant, E.R.2
Zhong, Z.3
-
35
-
-
0034046831
-
In vitro characterization of anti-glucosylceramide rabbit antisera
-
Brade L, Vielhaber G, Heinz E, Brade H. In vitro characterization of anti-glucosylceramide rabbit antisera. Glycobiology 2000; 10: 629-36.
-
(2000)
Glycobiology
, vol.10
, pp. 629-636
-
-
Brade, L.1
Vielhaber, G.2
Heinz, E.3
Brade, H.4
-
36
-
-
52449087540
-
Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus
-
Moroz N, Tong M, Longato L, Xu H, de la Monte SM. Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus. J Alzheimers Dis 2008; 15: 29-44.
-
(2008)
J Alzheimers Dis
, vol.15
, pp. 29-44
-
-
Moroz, N.1
Tong, M.2
Longato, L.3
Xu, H.4
de la Monte, S.M.5
-
37
-
-
77957259099
-
Ceramide-mediated insulin resistance and impairment of cognitive-motor functions
-
de la Monte SM, Tong M, Nguyen V, Setshedi M, Longato L, Wands JR. Ceramide-mediated insulin resistance and impairment of cognitive-motor functions. J Alzheimers Dis 2010; 21: 967-84.
-
(2010)
J Alzheimers Dis
, vol.21
, pp. 967-984
-
-
de la Monte, S.M.1
Tong, M.2
Nguyen, V.3
Setshedi, M.4
Longato, L.5
Wands, J.R.6
-
38
-
-
33747072601
-
Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms
-
Cantarini MC, de la Monte SM, Pang M etal. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Hepatology 2006; 44: 446-57.
-
(2006)
Hepatology
, vol.44
, pp. 446-457
-
-
Cantarini, M.C.1
de la Monte, S.M.2
Pang, M.3
-
39
-
-
0036282840
-
Chronic gestational exposure to ethanol impairs insulin-stimulated survival and mitochondrial function in cerebellar neurons
-
de la Monte SM, Wands JR. Chronic gestational exposure to ethanol impairs insulin-stimulated survival and mitochondrial function in cerebellar neurons. CMLS, Cell Mol Life Sci 2002; 59: 882-93.
-
(2002)
CMLS, Cell Mol Life Sci
, vol.59
, pp. 882-893
-
-
de la Monte, S.M.1
Wands, J.R.2
-
40
-
-
33748478598
-
Chronic gestational exposure to ethanol causes insulin and IGF resistance and impairs acetylcholine homeostasis in the brain
-
Soscia SJ, Tong M, Xu XJ etal. Chronic gestational exposure to ethanol causes insulin and IGF resistance and impairs acetylcholine homeostasis in the brain. Cell Mol Life Sci 2006; 63: 2039-56.
-
(2006)
Cell Mol Life Sci
, vol.63
, pp. 2039-2056
-
-
Soscia, S.J.1
Tong, M.2
Xu, X.J.3
-
41
-
-
0034693756
-
The contradictions of the insulin-like growth factor 1 receptor
-
Baserga R. The contradictions of the insulin-like growth factor 1 receptor. Oncogene 2000; 19: 5574-81.
-
(2000)
Oncogene
, vol.19
, pp. 5574-5581
-
-
Baserga, R.1
-
42
-
-
33749342069
-
Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin
-
Draznin B. Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin. Diabetes 2006; 55: 2392-7.
-
(2006)
Diabetes
, vol.55
, pp. 2392-2397
-
-
Draznin, B.1
-
43
-
-
0034975220
-
The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity
-
Kraegen EW, Cooney GJ, Ye JM, Thompson AL, Furler SM. The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity. Exp Clin Endocrinol Diabetes 2001; 109 (Suppl 2): S189-201.
-
(2001)
Exp Clin Endocrinol Diabetes
, vol.109
, Issue.2 SUPPL.
-
-
Kraegen, E.W.1
Cooney, G.J.2
Ye, J.M.3
Thompson, A.L.4
Furler, S.M.5
-
44
-
-
0346729968
-
Ceramide content is increased in skeletal muscle from obese insulin-resistant humans
-
Adams JM, 2nd, Pratipanawatr T, Berria R etal. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 2004; 53: 25-31.
-
(2004)
Diabetes
, vol.53
, pp. 25-31
-
-
Adams 2nd, J.M.1
Pratipanawatr, T.2
Berria, R.3
-
47
-
-
0035513703
-
Ceramide mediates insulin resistance by tumor necrosis factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state
-
Teruel T, Hernandez R, Lorenzo M. Ceramide mediates insulin resistance by tumor necrosis factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. Diabetes 2001; 50: 2563-71.
-
(2001)
Diabetes
, vol.50
, pp. 2563-2571
-
-
Teruel, T.1
Hernandez, R.2
Lorenzo, M.3
-
48
-
-
52049088770
-
Oxidative stress and covalent modification of protein with bioactive aldehydes
-
Grimsrud PA, Xie H, Griffin TJ, Bernlohr DA. Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem 2008; 283: 21837-41.
-
(2008)
J Biol Chem
, vol.283
, pp. 21837-21841
-
-
Grimsrud, P.A.1
Xie, H.2
Griffin, T.J.3
Bernlohr, D.A.4
-
49
-
-
58249110569
-
Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species
-
Bashan N, Kovsan J, Kachko I, Ovadia H, Rudich A. Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Physiol Rev 2009; 89: 27-71.
-
(2009)
Physiol Rev
, vol.89
, pp. 27-71
-
-
Bashan, N.1
Kovsan, J.2
Kachko, I.3
Ovadia, H.4
Rudich, A.5
-
50
-
-
1642570319
-
Nitric oxide, oxidants, and protein tyrosine nitration
-
Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci USA 2004; 101: 4003-8.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 4003-4008
-
-
Radi, R.1
-
51
-
-
0022506194
-
Alterations in hepatocyte insulin receptors in rats fed a choline-deficient diet
-
Betschart JM, Virji MA, Perera MI, Shinozuka H. Alterations in hepatocyte insulin receptors in rats fed a choline-deficient diet. Cancer Res 1986; 46: 4425-30.
-
(1986)
Cancer Res
, vol.46
, pp. 4425-4430
-
-
Betschart, J.M.1
Virji, M.A.2
Perera, M.I.3
Shinozuka, H.4
-
52
-
-
0023220137
-
Modifications of cellular lipids induce insulin resistance in cultured hepatoma cells
-
Bruneau C, Hubert P, Waksman A, Beck JP, Staedel-Flaig C. Modifications of cellular lipids induce insulin resistance in cultured hepatoma cells. Biochim Biophys Acta 1987; 928: 297-304.
-
(1987)
Biochim Biophys Acta
, vol.928
, pp. 297-304
-
-
Bruneau, C.1
Hubert, P.2
Waksman, A.3
Beck, J.P.4
Staedel-Flaig, C.5
-
53
-
-
27744556268
-
Lipid microdomains and insulin resistance: is there a connection?
-
Ikonen E, Vainio S. Lipid microdomains and insulin resistance: is there a connection? Sci STKE 2005; 2005: pe3.
-
(2005)
Sci STKE
, vol.2005
-
-
Ikonen, E.1
Vainio, S.2
-
54
-
-
0028349162
-
Elevated protein tyrosine phosphatase activity and increased membrane viscosity are associated with impaired activation of the insulin receptor kinase in old rats
-
Nadiv O, Shinitzky M, Manu H etal. Elevated protein tyrosine phosphatase activity and increased membrane viscosity are associated with impaired activation of the insulin receptor kinase in old rats. Biochem J 1994; 298 (Pt 2): 443-50.
-
(1994)
Biochem J
, vol.298
, Issue.PART 2
, pp. 443-450
-
-
Nadiv, O.1
Shinitzky, M.2
Manu, H.3
-
55
-
-
34248205140
-
Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity
-
Aerts JM, Ottenhoff R, Powlson AS etal. Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity. Diabetes 2007; 56: 1341-9.
-
(2007)
Diabetes
, vol.56
, pp. 1341-1349
-
-
Aerts, J.M.1
Ottenhoff, R.2
Powlson, A.S.3
-
56
-
-
0025123408
-
1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo
-
Turinsky J, O'Sullivan DM, Bayly BP. 1, 2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo. J Biol Chem 1990; 265: 16880-5.
-
(1990)
J Biol Chem
, vol.265
, pp. 16880-16885
-
-
Turinsky, J.1
O'Sullivan, D.M.2
Bayly, B.P.3
-
57
-
-
34248228704
-
Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes
-
Zhao H, Przybylska M, Wu IH etal. Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes. Diabetes 2007; 56: 1210-18.
-
(2007)
Diabetes
, vol.56
, pp. 1210-1218
-
-
Zhao, H.1
Przybylska, M.2
Wu, I.H.3
-
58
-
-
33748794808
-
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury
-
Svegliati-Baroni G, Candelaresi C, Saccomanno S etal. A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. Am J Pathol 2006; 169: 846-60.
-
(2006)
Am J Pathol
, vol.169
, pp. 846-860
-
-
Svegliati-Baroni, G.1
Candelaresi, C.2
Saccomanno, S.3
-
59
-
-
33846322877
-
The role of cytokines in non-alcoholic steatohepatitis. A review
-
Copaci I, Micu L, Voiculescu M. The role of cytokines in non-alcoholic steatohepatitis. A review. J Gastrointestin Liver Dis 2006; 15: 363-73.
-
(2006)
J Gastrointestin Liver Dis
, vol.15
, pp. 363-373
-
-
Copaci, I.1
Micu, L.2
Voiculescu, M.3
-
60
-
-
0011918483
-
Insulin stimulates glyceraldehyde-3-phosphate dehydrogenase gene expression through cis-acting DNA sequences
-
Alexander MC, Lomanto M, Nasrin N, Ramaika C. Insulin stimulates glyceraldehyde-3-phosphate dehydrogenase gene expression through cis-acting DNA sequences. Proc Natl Acad Sci USA 1988; 85: 5092-6.
-
(1988)
Proc Natl Acad Sci USA
, vol.85
, pp. 5092-5096
-
-
Alexander, M.C.1
Lomanto, M.2
Nasrin, N.3
Ramaika, C.4
-
61
-
-
0035851205
-
Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells
-
Tremblay F, Marette A. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J Biol Chem 2001; 276: 38052-60.
-
(2001)
J Biol Chem
, vol.276
, pp. 38052-38060
-
-
Tremblay, F.1
Marette, A.2
-
62
-
-
4544220704
-
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
-
Um SH, Frigerio F, Watanabe M etal. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 2004; 431: 200-5.
-
(2004)
Nature
, vol.431
, pp. 200-205
-
-
Um, S.H.1
Frigerio, F.2
Watanabe, M.3
-
63
-
-
14244256097
-
Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance
-
Khamzina L, Veilleux A, Bergeron S, Marette A. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 2005; 146: 1473-81.
-
(2005)
Endocrinology
, vol.146
, pp. 1473-1481
-
-
Khamzina, L.1
Veilleux, A.2
Bergeron, S.3
Marette, A.4
-
64
-
-
66349088529
-
Hepatic triacylglycerol accumulation and insulin resistance
-
Nagle CA, Klett EL, Coleman RA. Hepatic triacylglycerol accumulation and insulin resistance. J Lipid Res 2009; 50: S74-S79.
-
(2009)
J Lipid Res
, vol.50
-
-
Nagle, C.A.1
Klett, E.L.2
Coleman, R.A.3
-
65
-
-
36349024819
-
A lipidomic analysis of nonalcoholic fatty liver disease
-
Puri P, Baillie RA, Wiest MM etal. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007; 46: 1081-90.
-
(2007)
Hepatology
, vol.46
, pp. 1081-1090
-
-
Puri, P.1
Baillie, R.A.2
Wiest, M.M.3
-
66
-
-
0025317854
-
1,2-Diacylglycerol and ceramide levels in rat skeletal muscle and liver in vivo. Studies with insulin, exercise, muscle denervation, and vasopressin
-
Turinsky J, Bayly BP, O'Sullivan DM. 1, 2-Diacylglycerol and ceramide levels in rat skeletal muscle and liver in vivo. Studies with insulin, exercise, muscle denervation, and vasopressin. J Biol Chem 1990; 265: 7933-8.
-
(1990)
J Biol Chem
, vol.265
, pp. 7933-7938
-
-
Turinsky, J.1
Bayly, B.P.2
O'Sullivan, D.M.3
-
67
-
-
77954427437
-
High fat diet induces ceramide and sphingomyelin formation in rat's liver nuclei
-
Chocian G, Chabowski A, Zendzian-Piotrowska M, Harasim E, Lukaszuk B, Gorski J. High fat diet induces ceramide and sphingomyelin formation in rat's liver nuclei. Mol Cell Biochem 2010; 340: 125-31.
-
(2010)
Mol Cell Biochem
, vol.340
, pp. 125-131
-
-
Chocian, G.1
Chabowski, A.2
Zendzian-Piotrowska, M.3
Harasim, E.4
Lukaszuk, B.5
Gorski, J.6
-
68
-
-
67649723058
-
Mechanisms of ceramide-mediated neurodegeneration
-
Tong M, de la Monte SM. Mechanisms of ceramide-mediated neurodegeneration. J Alzheimers Dis 2009; 16: 705-14.
-
(2009)
J Alzheimers Dis
, vol.16
, pp. 705-714
-
-
Tong, M.1
de la Monte, S.M.2
-
69
-
-
0024507576
-
Insulin-stimulated hexose transport and glucose oxidation in rat adipocytes is inhibited by sphingosine at a step after insulin binding
-
Robertson DG, DiGirolamo M, Merrill AH, Jr, Lambeth JD. Insulin-stimulated hexose transport and glucose oxidation in rat adipocytes is inhibited by sphingosine at a step after insulin binding. J Biol Chem 1989; 264: 6773-9.
-
(1989)
J Biol Chem
, vol.264
, pp. 6773-6779
-
-
Robertson, D.G.1
DiGirolamo, M.2
Merrill Jr., A.H.3
Lambeth, J.D.4
-
70
-
-
0040799180
-
Sphingosine, an inhibitor of protein kinase C, suppresses the insulin-like effects of growth hormone in rat adipocytes
-
Smal J, De Meyts P. Sphingosine, an inhibitor of protein kinase C, suppresses the insulin-like effects of growth hormone in rat adipocytes. Proc Natl Acad Sci USA 1989; 86: 4705-9.
-
(1989)
Proc Natl Acad Sci USA
, vol.86
, pp. 4705-4709
-
-
Smal, J.1
De Meyts, P.2
-
71
-
-
66349098674
-
Insulin-modulated Akt subcellular localization determines Akt isoform-specific signaling
-
Gonzalez E, McGraw TE. Insulin-modulated Akt subcellular localization determines Akt isoform-specific signaling. Proc Natl Acad Sci USA 2009; 106: 7004-9.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 7004-7009
-
-
Gonzalez, E.1
McGraw, T.E.2
-
72
-
-
31544433399
-
Inhibition of glycogen synthesis by increased lipid availability is associated with subcellular redistribution of glycogen synthase
-
Taylor AJ, Ye JM, Schmitz-Peiffer C. Inhibition of glycogen synthesis by increased lipid availability is associated with subcellular redistribution of glycogen synthase. J Endocrinol 2006; 188: 11-23.
-
(2006)
J Endocrinol
, vol.188
, pp. 11-23
-
-
Taylor, A.J.1
Ye, J.M.2
Schmitz-Peiffer, C.3
-
73
-
-
67349130083
-
Glycosphingolipids and insulin resistance
-
Langeveld M, Aerts JM. Glycosphingolipids and insulin resistance. Prog Lipid Res 2009; 48: 196-205.
-
(2009)
Prog Lipid Res
, vol.48
, pp. 196-205
-
-
Langeveld, M.1
Aerts, J.M.2
-
74
-
-
34548761482
-
Elevation of sphingoid base 1-phosphate as a potential contributor to hepatotoxicity in fumonisin B1-exposed mice
-
Kim DH, Lee YS, Lee YM, Oh S, Yun YP, Yoo HS. Elevation of sphingoid base 1-phosphate as a potential contributor to hepatotoxicity in fumonisin B1-exposed mice. Arch Pharm Res 2007; 30: 962-9.
-
(2007)
Arch Pharm Res
, vol.30
, pp. 962-969
-
-
Kim, D.H.1
Lee, Y.S.2
Lee, Y.M.3
Oh, S.4
Yun, Y.P.5
Yoo, H.S.6
-
75
-
-
67649763475
-
Acid sphingomyelinase deficiency prevents diet-induced hepatic triacylglycerol accumulation and hyperglycemia in mice
-
Deevska GM, Rozenova KA, Giltiay NV etal. Acid sphingomyelinase deficiency prevents diet-induced hepatic triacylglycerol accumulation and hyperglycemia in mice. J Biol Chem 2009; 284: 8359-68.
-
(2009)
J Biol Chem
, vol.284
, pp. 8359-8368
-
-
Deevska, G.M.1
Rozenova, K.A.2
Giltiay, N.V.3
-
76
-
-
43249083481
-
Free fatty acids and skeletal muscle insulin resistance
-
Kraegen EW, Cooney GJ. Free fatty acids and skeletal muscle insulin resistance. Curr Opin Lipidol 2008; 19: 235-41.
-
(2008)
Curr Opin Lipidol
, vol.19
, pp. 235-241
-
-
Kraegen, E.W.1
Cooney, G.J.2
-
77
-
-
58149478126
-
Effects of 4weeks recombinant human growth hormone administration on insulin resistance of skeletal muscle in rats
-
Park MJ, Jung SR, Jung HL, Craig BW, Lee CD, Kang HY. Effects of 4weeks recombinant human growth hormone administration on insulin resistance of skeletal muscle in rats. Yonsei Med J 2008; 31 (49): 1008-16.
-
(2008)
Yonsei Med J
, vol.31
, Issue.49
, pp. 1008-1016
-
-
Park, M.J.1
Jung, S.R.2
Jung, H.L.3
Craig, B.W.4
Lee, C.D.5
Kang, H.Y.6
-
78
-
-
29144531843
-
Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases
-
Seki S, Kitada T, Sakaguchi H. Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases. Hepatol Res 2005; 33: 132-4.
-
(2005)
Hepatol Res
, vol.33
, pp. 132-134
-
-
Seki, S.1
Kitada, T.2
Sakaguchi, H.3
-
79
-
-
41949140023
-
Characterization of ceramide synthase 2
-
Laviad EL. Characterization of ceramide synthase 2. J Biol Chem 2008; 283 (9): 5677-84.
-
(2008)
J Biol Chem
, vol.283
, Issue.9
, pp. 5677-5684
-
-
Laviad, E.L.1
-
80
-
-
50049090026
-
Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine and sphingosine 1-phosphate
-
Mao C. Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine and sphingosine 1-phosphate. Biochim Biophys Acta 2008; 1781 (9): 424-34.
-
(2008)
Biochim Biophys Acta
, vol.1781
, Issue.9
, pp. 424-434
-
-
Mao, C.1
|